Comparing the structure and photoluminescence properties of Bi-doped lead-free double perovskites prepared by solution-based synthesis and green mechanochemistry
Abstract
In search for less environmentally harmful materials, lead-free double halide perovskites (DPs) have emerged as promising candidates with tuneable photoluminescence properties. In this study, we present a comparative analysis of DPs with composition Cs2Ag0.4Na0.6BiyIn1-yCl6 (CANBIC, y = 0.01-0.04, y is Bi content in mol%) obtained via solution-based (SB) and green solvent-free mechanochemical (MC) methods. Comprehensive characterization of the resulting materials was performed via X-ray diffraction (XRD), thermogravimetric analysis (TGA), scanning and transmission electron microscopy (SEM/TEM), optical diffuse reflectance and photoluminescence (PL) spectroscopies. Both synthesis routes yielded cubic (Fm-3 m) perovskite structures, with all CANBIC samples exhibiting broad emission spectra ranging from 400 to 900 nm (1.3-3.1 eV), originating from the recombination of self-trapped excitons (STEs). Bi3+ doping significantly enhanced photoluminescence quantum yield (PLQY) up to 84%. The solution-based (SB) method produced samples with higher PLQY, attributed to improved control over particle morphology and dopant distribution as compared to the mechanochemistry (MC) route. Thermal analysis confirmed the structural integrity of CANBIC samples up to 300 °C, with no significant decomposition below ~ 560 °C, indicating their suitability for optoelectronic applications requiring moderate thermal stability. This work provides valuable insights into the relationship between synthesis…
Read the paper
Related studies
- Chaos and quantum thermalization
- The Dalton quantum chemistry program system
- Cord Blood Leptin and Adiponectin as Predictors of Adiposity in Children at 3 Years of Age: A Prospective Cohort Study
- Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes
- Stable adiabatic quantum batteries
- A novel self-lipid antigen targets human T cells against CD1c(+) leukemias
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.